{"count": 3, "results": [{"_id": "25787808", "pmid": 25787808, "title": "Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats.", "journal": "Neurol Sci", "authors": ["Wang T", "Cao X", "Zhang T", "Shi Q", "Chen Z", "Tang B"], "date": "2015-08-01T00:00:00Z", "doi": "10.1007/s10072-015-2127-z", "meta_date_publication": "2015 Aug", "meta_volume": "36", "meta_issue": "8", "meta_pages": "1397-402", "score": 50069.996, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @CHEMICAL_Levodopa @CHEMICAL_MESH:D007980 @@@L-DOPA@@@-induced @<m>DISEASE_Dyskinesia_Drug_Induced</m> @DISEASE_MESH:D004409 @@@abnormal involuntary movements@@@ of hemiparkinsonian @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Wang T, Cao X, Zhang T, Shi Q, Chen Z, Tang B. Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats. Neurol Sci. 2015 Aug;36(8):1397-402. PMID: 25787808", "BibTeX": "@article{25787808, title={Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats.}, author={Wang T and Cao X and Zhang T and Shi Q and Chen Z and Tang B}, journal={Neurol Sci}, volume={36}, number={8}, pages={1397-402}}"}}, {"_id": "23283428", "pmid": 23283428, "title": "Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (\"n-of-1\") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.", "journal": "Parkinsonism Relat Disord", "authors": ["Tison F", "Nègre-Pagès L", "Meissner WG", "Dupouy S", "Li Q", "Thiolat ML", "Thiollier T", "Galitzky M", "Ory-Magne F", "Milhet A", "Marquine L", "Spampinato U", "Rascol O", "Bezard E"], "date": "2013-04-01T00:00:00Z", "doi": "10.1016/j.parkreldis.2012.12.003", "meta_date_publication": "2013 Apr", "meta_volume": "19", "meta_issue": "4", "meta_pages": "416-21", "score": 50069.74, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ decreases @CHEMICAL_Levodopa @CHEMICAL_MESH:D007980 @@@levodopa@@@-induced @<m>DISEASE_Dyskinesia_Drug_Induced</m> @DISEASE_MESH:D004409 @@@dyskinesia@@@ in @SPECIES_9527 @@@monkeys@@@, but not in a randomized, placebo-controlled, multiple cross-over (\"n-of-1\") exploratory trial of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ against @CHEMICAL_Levodopa @CHEMICAL_MESH:D007980 @@@levodopa@@@-induced @<m>DISEASE_Dyskinesia_Drug_Induced</m> @DISEASE_MESH:D004409 @@@dyskinesia@@@ in @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Tison F, Nègre-Pagès L, Meissner WG, Dupouy S, Li Q, Thiolat ML, Thiollier T, Galitzky M, Ory-Magne F, Milhet A, Marquine L, Spampinato U, Rascol O, Bezard E. Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (\"n-of-1\") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. Parkinsonism Relat Disord. 2013 Apr;19(4):416-21. PMID: 23283428", "BibTeX": "@article{23283428, title={Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (\"n-of-1\") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.}, author={Tison F and Nègre-Pagès L and Meissner WG and Dupouy S and Li Q and Thiolat ML and Thiollier T and Galitzky M and Ory-Magne F and Milhet A and Marquine L and Spampinato U and Rascol O and Bezard E}, journal={Parkinsonism Relat Disord}, volume={19}, number={4}, pages={416-21}}"}}, {"_id": "31098725", "pmid": 31098725, "title": "Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.", "journal": "J Neural Transm (Vienna)", "authors": ["Delamarre A", "Tison F", "Li Q", "Galitzky M", "Rascol O", "Bezard E", "Meissner WG"], "date": "2019-06-01T00:00:00Z", "doi": "10.1007/s00702-019-02015-x", "meta_date_publication": "2019 Jun", "meta_volume": "126", "meta_issue": "6", "meta_pages": "789-793", "score": 50057.16, "text_hl": "Plasma @GENE_CMPK1 @GENE_51727 @@@CK@@@ levels were measured in five @DISEASE_Cerebral_Palsy @DISEASE_MESH:D002547 @@@dyskinetic@@@ @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@parkinsonian@@@ non-@SPECIES_9606 @@@human@@@ primates (NHP) and in ten @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@PD@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Dyskinesia_Drug_Induced</m> @DISEASE_MESH:D004409 @@@LID@@@ who participated in a treatment trial with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Delamarre A, Tison F, Li Q, Galitzky M, Rascol O, Bezard E, Meissner WG. Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease. J Neural Transm (Vienna). 2019 Jun;126(6):789-793. PMID: 31098725", "BibTeX": "@article{31098725, title={Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.}, author={Delamarre A and Tison F and Li Q and Galitzky M and Rascol O and Bezard E and Meissner WG}, journal={J Neural Transm (Vienna)}, volume={126}, number={6}, pages={789-793}}"}}]}